- Romifidine
-
- $10.00
-
2026-09-14
- CAS:65896-16-4
- Min. Order: 1ASSAYS
- Purity: 99%
- Supply Ability: 100 kg
- Romifidine
-
-
2026-06-30
- CAS:65896-16-4
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000KGS
- Romifidine
-
- $60.00
-
2026-05-11
- CAS:65896-16-4
- Purity:
- Supply Ability: 10g
|
| | Romifidine Basic information |
| Product Name: | Romifidine | | Synonyms: | 2-(2-Bromo-6-fluoroanilino)-2-imidazoline;Romidys;St 2130;STH 2130;Romifidine;N-(2-Bromo-6-fluorophenyl)-4,5-dihydro-1H-imidazol-2-amine;Romifidine >;1H-Imidazol-2-amine, N-(2-bromo-6-fluorophenyl)-4,5-dihydro- | | CAS: | 65896-16-4 | | MF: | C9H9BrFN3 | | MW: | 258.09 | | EINECS: | 202-303-5 | | Product Categories: | | | Mol File: | 65896-16-4.mol |  |
| | Romifidine Chemical Properties |
| Melting point | 110 °C | | Boiling point | 303.2±52.0 °C(Predicted) | | density | 1.72±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 250 mg/mL (968.65 mM; Need ultrasonic) | | form | powder to crystal | | pka | 8.69±0.50(Predicted) | | color | White to Light yellow |
| | Romifidine Usage And Synthesis |
| Uses | Romifidine is an α2 adrenergic receptor agonist. Romifidine shows sedation effects in vivo[1][2]. | | in vivo | Romifidine (80 μg/kg; i.v. once) produces sedative effects with significantly greater drooping during the 45-90 min time period in welsh mountain ponies[1].
Romifidine (40, 80 and 120 mg/kg; i.v. at seven-day intervals) shows a shallower and shorter-lived sedation than with detomidine in horses[2]. | | References | [1] England GC, et al. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse. J Vet Pharmacol Ther. 1992 Jun;15(2):194-201. DOI:10.1111/j.1365-2885.1992.tb01007.x
[2] Hamm D, et al. Sedative and analgesic effects of detomidine and romifidine in horses. Vet Rec. 1995 Apr 1;136(13):324-7. DOI:10.1136/vr.136.13.324 |
| | Romifidine Preparation Products And Raw materials |
|